Bartholomew J. Naughton

Feasibility and Safety of Systemic rAAV9-h<i>NAGLU</i> Delivery for Treating Mucopolysaccharidosis IIIB: Toxicology, Biodistribution, and Immunological Assessments in Primates

Darren Murrey, Bartholomew J. Naughton, F. Jason Duncan et al. · Human Gene Therapy Clinical Development · 2014 · 87 citations · Full text

Mucopolysaccharidosis Iiib, Immunotoxicology, Immunodeficiencies +18

Blood Genome-Wide Transcriptional Profiles Reflect Broad Molecular Impairments and Strong Blood-Brain Links in Alzheimer's Disease

Bartholomew J. Naughton, F. Jason Duncan, Darren Murrey et al. · Journal of Alzheimer s Disease · 2014 · 58 citations · Full text

Neurogenomics, Genetics, Neurochemical Biomarkers +23

Dopamine transporter inhibition is necessary for cocaine‐induced increases in dendritic spine density in the nucleus accumbens

Bradley J. Martin, Bartholomew J. Naughton, Keerthi Thirtamara Rajamani et al. · Synapse · 2010 · 37 citations

Synaptic Transmission, Neurotransmitter, Locomotor Activity +23

Observational Study of PD-L1, TGF-β, and Immune Cell Infiltrates in Hepatocellular Carcinoma

Christian Ihling, Bartholomew J. Naughton, Yue Zhang et al. · Frontiers in Medicine · 2019 · 30 citations · Full text

Broad Functional Correction of Molecular Impairments by Systemic Delivery of scAAVrh74-hSGSH Gene Delivery in MPS IIIA Mice

F. Jason Duncan, Bartholomew J. Naughton, Kimberly Zaraspe et al. · Molecular Therapy · 2015 · 25 citations · Full text

Root Cause, Immunology, Gene Delivery +17